54 related articles for article (PubMed ID: 3188961)
1. [Correlation between myocardial relaxation and phosphorylation of phospholamban].
Vittone L; Mundiña C; Chiappe de Cingolani G; Mattiazzi A
Acta Physiol Pharmacol Latinoam; 1988; 38(2):213-27. PubMed ID: 3188961
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between contraction and relaxation: the possible role of phospholamban phosphorylation.
Mundiña de Weilenmann C; Vittone L; de Cingolani G; Mattiazzi A
Basic Res Cardiol; 1987; 82(6):507-16. PubMed ID: 2963614
[TBL] [Abstract][Full Text] [Related]
3. Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.
Linck B; Bokník P; Baba HA; Eschenhagen T; Haverkamp U; Jäckel E; Jones LR; Kirchhefer U; Knapp J; Läer S; Müller FU; Schmitz W; Scholz H; Syska A; Vahlensieck U; Neumann J
J Pharmacol Exp Ther; 1998 Jul; 286(1):531-8. PubMed ID: 9655899
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of propranolol on myocardial relaxation not mediated by beta blockade].
Pedroni P; Mattiazzi A; Gende OA; Cingolani HE
Acta Physiol Pharmacol Latinoam; 1987; 37(4):503-19. PubMed ID: 3274025
[TBL] [Abstract][Full Text] [Related]
5. Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways.
Vittone L; Mundiña-Weilenmann C; Said M; Ferrero P; Mattiazzi A
J Mol Cell Cardiol; 2002 Jan; 34(1):39-50. PubMed ID: 11812163
[TBL] [Abstract][Full Text] [Related]
6. Insulin inhibits beta-adrenergic action in ischemic/reperfused heart: a novel mechanism of insulin in cardioprotection.
Yu QJ; Si R; Zhou N; Zhang HF; Guo WY; Wang HC; Gao F
Apoptosis; 2008 Feb; 13(2):305-17. PubMed ID: 18165901
[TBL] [Abstract][Full Text] [Related]
7. Role of phosphorylation of Thr(17) residue of phospholamban in mechanical recovery during hypercapnic acidosis.
Mundiña-Weilenmann C; Ferrero P; Said M; Vittone L; Kranias EG; Mattiazzi A
Cardiovasc Res; 2005 Apr; 66(1):114-22. PubMed ID: 15769454
[TBL] [Abstract][Full Text] [Related]
8. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
Mattiazzi A; Mundiña-Weilenmann C; Guoxiang C; Vittone L; Kranias E
Cardiovasc Res; 2005 Dec; 68(3):366-75. PubMed ID: 16226237
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of phospholamban in ischemia-reperfusion injury: functional role of Thr17 residue.
Mattiazzi A; Mundiña-Weilenmann C; Vittone L; Said M
Mol Cell Biochem; 2004 Aug; 263(1-2):131-6. PubMed ID: 15524173
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.
Bartel S; Vetter D; Schlegel WP; Wallukat G; Krause EG; Karczewski P
J Mol Cell Cardiol; 2000 Dec; 32(12):2173-85. PubMed ID: 11112993
[TBL] [Abstract][Full Text] [Related]
11. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of phospholamban and troponin I in the ischemic and reperfused heart: attenuation and restoration of isoprenaline responsiveness.
Bartel S; Karczewski P; Krause EG
Biomed Biochim Acta; 1989; 48(2-3):S108-13. PubMed ID: 2525030
[TBL] [Abstract][Full Text] [Related]
13. Enhanced myocardial relaxation in vivo in transgenic mice overexpressing the beta2-adrenergic receptor is associated with reduced phospholamban protein.
Rockman HA; Hamilton RA; Jones LR; Milano CA; Mao L; Lefkowitz RJ
J Clin Invest; 1996 Apr; 97(7):1618-23. PubMed ID: 8601626
[TBL] [Abstract][Full Text] [Related]
14. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
[TBL] [Abstract][Full Text] [Related]
15. Decrease in time to peak tension produced by calcium blockers and isoproterenol. Its dependence on extracellular calcium.
Garay A; Mattiazzi A
Acta Physiol Lat Am; 1982; 32(4):295-302. PubMed ID: 7186745
[TBL] [Abstract][Full Text] [Related]
16. Lusitropic effect of MCC-135 is associated with improvement of sarcoplasmic reticulum function in ventricular muscles of rats with diabetic cardiomyopathy.
Satoh N; Sato T; Shimada M; Yamada K; Kitada Y
J Pharmacol Exp Ther; 2001 Sep; 298(3):1161-6. PubMed ID: 11504815
[TBL] [Abstract][Full Text] [Related]
17. Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
Kadambi VJ; Koss KL; Grupp IL; Kranias EG
J Mol Cell Cardiol; 1998 Jul; 30(7):1275-84. PubMed ID: 9710796
[TBL] [Abstract][Full Text] [Related]
18. Troponin I phosphorylation plays an important role in the relaxant effect of beta-adrenergic stimulation in mouse hearts.
Peña JR; Wolska BM
Cardiovasc Res; 2004 Mar; 61(4):756-63. PubMed ID: 14985072
[TBL] [Abstract][Full Text] [Related]
19. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites.
Takimoto E; Soergel DG; Janssen PM; Stull LB; Kass DA; Murphy AM
Circ Res; 2004 Mar; 94(4):496-504. PubMed ID: 14726477
[TBL] [Abstract][Full Text] [Related]
20. Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failure.
Antoons G; Vangheluwe P; Volders PG; Bito V; Holemans P; Ceci M; Wuytack F; Caroni P; Mubagwa K; Sipido KR
J Mol Cell Cardiol; 2006 Mar; 40(3):350-60. PubMed ID: 16427649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
